These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22040407)

  • 21. Transcriptional changes in U343 MG-a glioblastoma cell line exposed to ionizing radiation.
    Bassi C; Mello SS; Cardoso RS; Godoy PD; Fachin AL; Junta CM; Sandrin-Garcia P; Carlotti CG; Falcão RP; Donadi EA; Passos GA; Sakamoto-Hojo ET
    Hum Exp Toxicol; 2008 Dec; 27(12):919-29. PubMed ID: 19273547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
    Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
    J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.
    Marko NF; Toms SA; Barnett GH; Weil R
    Genomics; 2008 May; 91(5):395-406. PubMed ID: 18343632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival.
    Ernst A; Hofmann S; Ahmadi R; Becker N; Korshunov A; Engel F; Hartmann C; Felsberg J; Sabel M; Peterziel H; Durchdewald M; Hess J; Barbus S; Campos B; Starzinski-Powitz A; Unterberg A; Reifenberger G; Lichter P; Herold-Mende C; Radlwimmer B
    Clin Cancer Res; 2009 Nov; 15(21):6541-50. PubMed ID: 19861460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.
    Colin C; Baeza N; Bartoli C; Fina F; Eudes N; Nanni I; Martin PM; Ouafik L; Figarella-Branger D
    Oncogene; 2006 May; 25(19):2818-26. PubMed ID: 16314830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glioblastoma-specific protein interaction network identifies PP1A and CSK21 as connecting molecules between cell cycle-associated genes.
    Ladha J; Donakonda S; Agrawal S; Thota B; Srividya MR; Sridevi S; Arivazhagan A; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Kondaiah P; Somasundaram K; Santosh V; Rao SM
    Cancer Res; 2010 Aug; 70(16):6437-47. PubMed ID: 20663907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative immunohistochemical analysis of aurora-A and aurora-B expression in human glioblastomas. Associations with proliferative activity and clinicopathological features.
    Samaras V; Stamatelli A; Samaras E; Arnaoutoglou C; Arnaoutoglou M; Stergiou I; Konstantopoulou P; Varsos V; Karameris A; Barbatis C
    Pathol Res Pract; 2009; 205(11):765-73. PubMed ID: 19616898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression patterns of Aurora A and B kinases, Ki-67 and the estrogen and progesterone receptors determined using an endometriosis tissue microarray model.
    Calcagno A; Grassi T; Mariuzzi L; Marzinotto S; Londero AP; Orsaria M; Beltrami CA; Marchesoni D
    Hum Reprod; 2011 Oct; 26(10):2731-41. PubMed ID: 21840910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions.
    Avril T; Saikali S; Vauleon E; Jary A; Hamlat A; De Tayrac M; Mosser J; Quillien V
    J Neuroimmunol; 2010 Aug; 225(1-2):22-33. PubMed ID: 20493562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme.
    Vogel TW; Zhuang Z; Li J; Okamoto H; Furuta M; Lee YS; Zeng W; Oldfield EH; Vortmeyer AO; Weil RJ
    Clin Cancer Res; 2005 May; 11(10):3624-32. PubMed ID: 15897557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiling from formalin-fixed paraffin-embedded tumors of pediatric glioblastoma.
    Haque T; Faury D; Albrecht S; Lopez-Aguilar E; Hauser P; Garami M; Hanzély Z; Bognár L; Del Maestro RF; Atkinson J; Nantel A; Jabado N
    Clin Cancer Res; 2007 Nov; 13(21):6284-92. PubMed ID: 17975139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathway analysis of coronary atherosclerosis.
    King JY; Ferrara R; Tabibiazar R; Spin JM; Chen MM; Kuchinsky A; Vailaya A; Kincaid R; Tsalenko A; Deng DX; Connolly A; Zhang P; Yang E; Watt C; Yakhini Z; Ben-Dor A; Adler A; Bruhn L; Tsao P; Quertermous T; Ashley EA
    Physiol Genomics; 2005 Sep; 23(1):103-18. PubMed ID: 15942018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
    Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
    J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
    Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
    Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer.
    Sabine VS; Sims AH; Macaskill EJ; Renshaw L; Thomas JS; Dixon JM; Bartlett JM
    Breast Cancer Res Treat; 2010 Jul; 122(2):419-28. PubMed ID: 20480226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular markers of extracellular matrix remodeling in glioblastoma vessels: microarray study of laser-captured glioblastoma vessels.
    Pen A; Moreno MJ; Martin J; Stanimirovic DB
    Glia; 2007 Apr; 55(6):559-72. PubMed ID: 17266141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A fourteen gene GBM prognostic signature identifies association of immune response pathway and mesenchymal subtype with high risk group.
    Arimappamagan A; Somasundaram K; Thennarasu K; Peddagangannagari S; Srinivasan H; Shailaja BC; Samuel C; Patric IR; Shukla S; Thota B; Prasanna KV; Pandey P; Balasubramaniam A; Santosh V; Chandramouli BA; Hegde AS; Kondaiah P; Sathyanarayana Rao MR
    PLoS One; 2013; 8(4):e62042. PubMed ID: 23646114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.